John Brendan Doyle Cognition Therapeutics Inc (CGTX) insider trading activity

John Brendan Doyle is Chief Financial Officer of COGNITION THERAPEUTICS INC. Currently has a direct ownership of 425,350 shares of CGTX, which is worth approximately $1.03 Million. The most recent transaction as insider was on Jul 29, 2025, when has been sold 9,360 shares (Common Stock) at a price of $0.67 per share, resulting in proceeds of $6,271. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 425K

5.1% 3M change

251.17% 12M change

Total Value Held $1.03 Million

John Brendan Doyle Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 29 2025	SELL Payment of exercise price or tax liability	$6,271 $0.67 p/Share	9,360 Reduced 2.15%	425,350 Common Stock
Jul 29 2025	BUY Grant, award, or other acquisition	-	30,000 Added 6.46%	434,710 Common Stock
May 01 2025	SELL Payment of exercise price or tax liability	$4,361 $0.45 p/Share	9,692 Reduced 2.34%	404,710 Common Stock
Feb 15 2025	SELL Payment of exercise price or tax liability	$1,016 $0.59 p/Share	1,723 Reduced 0.41%	414,402 Common Stock
Feb 04 2025	BUY Grant, award, or other acquisition	-	295,000 Added 41.48%	416,125 Common Stock
May 01 2024	SELL Payment of exercise price or tax liability	$16,963 $1.95 p/Share	8,699 Reduced 6.7%	121,125 Common Stock
Feb 15 2024	BUY Grant, award, or other acquisition	-	20,000 Added 13.35%	129,824 Common Stock
May 01 2023	BUY Grant, award, or other acquisition	-	109,824 Added 50.0%	109,824 Common Stock

JBD

John Brendan Doyle

Chief Financial Officer

Purchase, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CGTX shares.

Notify only if

Value

Insider Trading

Get notified when an Cognition Therapeutics Inc insider buys or sells CGTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to COGNITION THERAPEUTICS INC

Track Activities on CGTX

Account